Viggo F I Van Tendeloo (Viggo Van Tendeloo, Viggo F Van Tendeloo, V F I Van Tendeloo, Viggo F van Tendeloo)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Dendritic Cells

Tyrosine Kinase

Top Venues

Cancer immunology, immunotherapy : CII

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marlies Boeren, Elise Van Breedam, Tamariche Buyle-Huybrecht, Marielle Lebrun, Pieter Meysman, Catherine Sadzot-Delvaux, Viggo F I Van Tendeloo, Geert Mortier, Kris Laukens, Benson Ogunjimi, Peter Ponsaerts, Peter Luc Delputte
Activation of Interferon-Stimulated Genes following Varicella-Zoster Virus Infection in a Human iPSC-Derived Neuronal In Vitro Model Depends on Exogenous Interferon-α. Viruses 14 (11) (2022)
Diana Campillo-Davo, Maxime De Laere, Gils Roex, Maarten Versteven, Donovan Flumens, Zwi N Berneman, Viggo F I Van Tendeloo, Sébastien Anguille, Eva Lion
The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy. Pharmaceutics 13 (3) (2021)
Stephanie Jordaens, Leah Cooksey, Stephanie Bonney, Laurence Orchard, Matthew Coutinho, Viggo F I Van Tendeloo, Kenneth Ian Mills, Kim H Orchard, Barbara-Ann Guinn
Serum profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia. British journal of haematology 189 (3) (2020)
Stephanie Jordaens, Leah Cooksey, Laurie Freire Boullosa, Viggo F I Van Tendeloo, Evelien L J Smits, Kenneth Ian Mills, Kim H Orchard, Barbara-Ann Guinn
New targets for therapy: antigen identification in adults with B-cell acute lymphoblastic leukaemia. Cancer immunology, immunotherapy : CII 69 (5) (2020)
Rodriguez-Perez Ar, Diana Campillo-Davo, Viggo F I Van Tendeloo, Daniel Benítez-Ribas
Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (11) (2020)
Heleen H Van Acker, Maarten Versteven, Felix S Lichtenegger, Gils Roex, Diana Campillo-Davo, Eva Lion, Marion Subklewe, Viggo F I Van Tendeloo, Zwi N Berneman, Sébastien Anguille
Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia. Journal of clinical medicine 8 (5) (2019)
Sévérine de Bruijn, Sébastien Anguille, Joris Verlooy, Evelien L Smits, Viggo F I Van Tendeloo, Maxime de Laere, Koenraad Norga, Zwi N Berneman, Eva Lion
Dendritic Cell-Based and Other Vaccination Strategies for Pediatric Cancer. Cancers 11 (9) (2019)
Heleen H Van Acker, Zoë P Van Acker, Maarten Versteven, Peter Ponsaerts, Daniela Pende, Zwi N Berneman, Sébastien Anguille, Viggo F I Van Tendeloo, Evelien L J Smits
CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15. Cancers 11 (7) (2019)
Thomas J van Ee, Heleen H Van Acker, Tom G van Oorschot, Viggo F I Van Tendeloo, Evelien L Smits, Ghaith Bakdash, I Jolanda M de Vries
BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target? Vaccines 6 (3) (2018)